Rallybio Revenue

In the year 2025, Rallybio had annual revenue of $858.00K with 34.91% growth. Rallybio had revenue of $222.00K in the quarter ending December 31, 2025, with 484.21% growth.

Revenue (ttm)

$858.00K

Revenue Growth

+34.91%

P/S Ratio

54.75

Revenue / Employee

$61,286

Employees

Market Cap

47.87M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	858.00K	222.00K	34.91%
Dec 31, 2024	636.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Xilio Therapeutics	43.77M
Cue Biopharma	27.47M
Radiopharm Theranostics	10.86M
Nutriband	2.28M
Hyperion DeFi	813.46K
Mereo BioPharma Group	500.00K
Entera Bio	42.00K

Revenue Rankings

RLYB News

2 months ago - Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism - Benzinga
2 months ago - Rallybio Transcript: M&A announcement - Transcripts
2 months ago - Rallybio Corporation and Candid Therapeutics Announce Merger Agreement - Business Wire
2 months ago - Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026 - Benzinga
2 months ago - Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement - Business Wire
3 months ago - Rallybio Announces Reverse Stock Split of Common Stock - Business Wire
3 months ago - Rallybio Transcript: EGM 2026 - Transcripts
6 months ago - Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire

More News